6
Oct
2026

LOTTE Biologics

Exhibitor at CPHI Milan 2026 stand 6F50, Contract Manufacturing & Services
About Us

LOTTE BIOLOGICS has a campus for biopharmaceutical production in the Syracuse of U.S. and is in the process of constructing a bio campus in the Songdo, Korea which will be operational by 2027.

  • Two sites in the U.S. and Korea with a unified quality system,
  • 20 years of commercial biologics manufacturing
  • Antibody and  ADC production in one U.S. location
  • Syracuse  Bio Campus : 40KL (5KL x 8)
  • Songdo Bio Campus : 120KL (15KL x 8) 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2022
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 6F50, Contract Manufacturing & Services

LOTTE Biologics Resources (1)